• Explore /
  • Poster
  • / Sunitinib in patients with pancreatic neuroendocrine tumors (panNETs): Exploratory pharmacogenomic analyses.

Sunitinib in patients with pancreatic neuroendocrine tumors (panNETs): Exploratory pharmacogenomic analyses.

Abstract Poster

Authors

Nicola Fazio

Nicola Fazio

European Institute of Oncology, Milan, Italy

Nicola Fazio , Jean-Francois Martini , Adina-Emilia Croitoru , Michael Schenker , Sherry Li , Brad Rosbrook , Kathrine C. Fernandez , Jiri Tomasek , Espen Thiis-Evensen , Matthew H. Kulke , Eric Raymond

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Translational Research

Clinical Trial Registration Number

NCT01525550

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 255)

DOI

10.1200/JCO.2019.37.4_suppl.255

Abstract #

255

Poster Bd #

D13

Abstract Disclosures

Similar Posters

First Author: Gerard A. Milano

First Author: Stefan Kubicka

First Author: Jaume Capdevila

First Author: Enrique Grande